公司资料
Hims & Hers 股价、新闻与催化剂
- 股票代码:
- HIMS
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
27.89 USD (-0.39%)
收盘价
最后更新: 2026年9月17日
6.37B USD
市值
股价为何变动
截至 2026年9月17日，HIMS 下跌 0.39%，收于 $27.89。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Hims sits in digital health and consumer services.
商业模式特征
The business depends on subscription economics, branded consumer demand, and the ability to expand across adjacent self-pay healthcare categories.
生物医药行业定位
Hims is not a biotech name, but it is a fast-growing healthcare platform whose stock reacts to customer growth and monetization.
未来催化剂
- Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base. The company matters most when new categories turn into recurring subscribers rather than one-time spikes.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。